Tyrosine O-GalNAc Alters the Conformation and Proteolytic Susceptibility of APP Model Glycopeptides

ACS Chem Neurosci. 2021 Aug 18;12(16):2974-2980. doi: 10.1021/acschemneuro.1c00387. Epub 2021 Jul 29.

Abstract

The amyloid-β precursor protein (APP) undergoes proteolytic cleavage by α-, β-, and γ-secretases, to determine its fate in Alzheimer's disease (AD) pathogenesis. Recent findings suggest a possible role of O-glycosylation in APP's proteolytic processing. Therefore, we synthesized native and Swedish-double-mutated APP (glyco)peptides with Tyr681-O-GalNAc. We studied conformational changes and proteolytic processing using circular dichroism (CD) spectroscopy and enzyme cleavage assay, respectively. CD analysis was carried out in four solvent systems to evaluate peptide environment and O-glycosylation induced conformational changes. The Swedish mutation and Tyr681-O-GalNAc were the key factors driving conformational changes. Furthermore, the level of α- and β-secretase activity was increased by the presence of mutation and this effect was more pronounced for its glycosylated analogues. Our results suggest that O-glycosylation of Tyr681 can induce a conformational change in APP and affect its proteolytic processing fate toward the amyloidogenic pathway.

Keywords: APP; Alzheimer’s disease (AD); CD analysis; O-glycosylation; proteolytic cleavage; tyrosine.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease*
  • Amyloid Precursor Protein Secretases
  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor* / genetics
  • Glycopeptides
  • Humans
  • Tyrosine

Substances

  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Glycopeptides
  • Tyrosine
  • Amyloid Precursor Protein Secretases